ロード中...
High-dose methotrexate for elderly patients with primary CNS lymphoma
The introduction of methotrexate (MTX)-based chemotherapy has improved median survival for patients with primary CNS lymphoma (PCNSL). Older age is a negative prognostic marker in patients with PCNSL and may increase the likelihood of MTX toxicity. We studied the response and adverse effects of intr...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Duke University Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2718993/ https://ncbi.nlm.nih.gov/pubmed/18757775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2008-067 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|